Gefitinib (ZD1839) is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the ...
IRESSA® (gefitinib) is a treatment for patients. ... IRESSA® gefitinib logo. For US Consumers; Go to US Healthcare Professional Site · Register for Updates ...
Easy to read patient leaflet for gefitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.
Gefitinib (Iressa) targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of non-small cell lung cancer.
Dec 15, 2015 ... Gefitinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Oct 5, 2006 ... This page contains brief information about gefitinib and a collection of links to more information about the use of this drug, research results, and ...
Information from the FDA about the approval of this drug and the clinical trials that led to the approval.
Jun 24, 2010 ... Original Article from The New England Journal of Medicine — Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR.
Jul 30, 2015 ... The drug that started it all in lung cancer is back! By that I mean gefitinib (Iressa), the first targeted therapy ever approved for lung cancer.
Find patient medical information for gefitinib-tablet on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.